Clinical Reflections on the SSRI and Pregnancy FDA Panel

Clinical Reflections on the SSRI and Pregnancy FDA Panel

BRAIN TRUST: CONVERSATIONS IN PSYCHOPHARMACOLOGY -Series Editor Joseph F. Goldberg, MD Joseph F. Goldberg, MD: Hello…

Continue Reading
A Response to the FDA’s SSRI Panel Discussion

A Response to the FDA’s SSRI Panel Discussion

Syda Productions/Adobe Stock As a psychiatrist specialized in perinatal and infant mental health, I have seen…

Continue Reading
Antidepressants in pregnancy: Doctors decry ‘misinformation’ after FDA panel meets : Shots

Antidepressants in pregnancy: Doctors decry ‘misinformation’ after FDA panel meets : Shots

Doctors are criticizing a recent expert panel organized by the U.S. Food and Drug Administration that…

Continue Reading
FDA Panel Casts Doubt on Safety of SSRI Use in Pregnancy

FDA Panel Casts Doubt on Safety of SSRI Use in Pregnancy

On Monday, July 21, a 10-member panel headed by Marty Makary, MD, MPH, commissioner of the…

Continue Reading
FDA panel on SSRI antidepressants in pregnancy raises alarms

FDA panel on SSRI antidepressants in pregnancy raises alarms

The U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a…

Continue Reading
FDA panel weighs risks, benefits of antidepressants during pregnancy

FDA panel weighs risks, benefits of antidepressants during pregnancy

Add topic to email alerts Receive an email when new articles…

Continue Reading
FDA panel promotes misinformation about antidepressants during pregnancy, psychiatrists say

FDA panel promotes misinformation about antidepressants during pregnancy, psychiatrists say

A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted…

Continue Reading